JAGSONPAL PHARMACEUTICALS LTD

JAGSNPHARM BSE
JAGSNPHARM
JAGSONPAL PHARMACEUTICALS LTD BSE
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

JAGSNPHARM financial statements: Income statement

JAGSONPAL PHARMACEUTICALS LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of JAGSNPHARM for the last quarter is 594.89M, and it's 0.85% lower compared to the previous quarter. The net income of Q2 21 is 73.07M.

TTM
Gross profit
Total revenue
Cost of goods sold
Operating expenses (excl. COGS)
Operating income
Non-operating income, total
Pretax income
Equity in earnings
Taxes
Non-controlling/minority interest
After tax other income/expense
Net income before discontinued operations
Discontinued operations
Net income
Dilution adjustment
Preferred dividends
Diluted net income available to common stockholders
Basic earnings per share (Basic EPS)
Diluted earnings per share (Diluted EPS)
Average basic shares outstanding
Diluted shares outstanding
EBITDA
EBIT
Total operating expenses